// App-Quantinova.ai

TCT-204 : Evaluation and Validation of the Beckman-Coulter ACCESS High Sensitivity Troponin I Assay using a Novel Single Cut-Off Strategy for an Early Rule Out Acute Coronary Syndrome Protocol (ACS-ERP) in a Real-World Emergency Department Population

Researchers

Presenter

  • Kalaivani Mahadevan

Principal Investigators

  • Chloe Walster

  • Georgina Latcham

  • Amy Carolin

  • Alex Hobson

Medical Centers

  • Bristol Heart Institute, Bristol, United Kingdom

  • Portsmouth, United Kingdom

  • Portsmouth Hospitals NHS Trust

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

Biomarkers

  • Troponin I

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Observational

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved